Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Campbell Laboratories was a specialty pharmaceutical company primarily focused on the development and manufacture of over-the-counter (OTC) dermatological and lip care products. The company is most notably recognized for creating Herpecin-L, a medicated lip balm that became a leading treatment for cold sores, sun-damaged lips, and fever blisters. Founded in the mid-20th century, the company established a strong presence in the consumer healthcare market before its core assets were acquired. In 1990, the Herpecin-L brand was sold to Chattem, Inc., which was later acquired by Sanofi, where the product continues to be marketed today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Campbell Laboratories.